Related Experiment Video
Updated: Dec 2, 2025
08:48
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
Published on: January 29, 2016
17.1K
Adult polyglucosan body disease - Management and evolution in an intensive rehabilitation program
I Carneiro1, M Rodrigues1, A João Costa1
1North Rehabilitation Center, Portugal.
Rehabilitacion
|November 3, 2020
Summary
Adult polyglucosan body disease (APBD) is a rare neuromuscular disorder. This case study details a comprehensive inpatient rehabilitation program for an adult patient, highlighting its potential benefits.
Area of Science:
- Neurology
- Genetics
- Rehabilitation Medicine
Background:
- Adult polyglucosan body disease (APBD) is a rare genetic neuromuscular disorder.
- It involves the accumulation of abnormal glycogen structures in the nervous system and muscles.
- Functional impairments and rehabilitation strategies for APBD are infrequently documented.
Observation:
- A 65-year-old female with a history of undiagnosed symptoms presented for physical and rehabilitation consultation.
- The patient was evaluated one year after receiving an APBD diagnosis.
Findings:
- An intensive inpatient rehabilitation program was designed and implemented.
- The program involved a multiprofessional and multidisciplinary team approach.
Implications:
- This case highlights a structured rehabilitation approach for APBD.
- Intensive, multidisciplinary care may be beneficial for managing functional impairments in APBD patients.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
195
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
195
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
525
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
525
01:24Cystic Fibrosis: Management
325
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
325
01:15Diabetes: Management and Pharmacotherapy
746
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
746